Heart Failure Drugs Market - Global Outlook and Forecast 2022-2028

January 2022 | 74 pages | ID: H85BCCA2D118EN
Market Monitor Global

Abstracts

Heart failure occurs when your heart muscle doesn't pump blood as well as it should.

This report contains market size and forecasts of Heart Failure Drugs in global, including the following market information:

Global Heart Failure Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global Heart Failure Drugs Market Sales, 2017-2022, 2023-2028, (MT)

Global top five Heart Failure Drugs companies in 2021 (%)

The global Heart Failure Drugs market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

ACEI Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Heart Failure Drugs include Novartis, Pfizer, AstraZeneca, Hikma, Teva, Cipla, Merck & Co., Amgen and Roche, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Heart Failure Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Heart Failure Drugs Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (MT)

Global Heart Failure Drugs Market Segment Percentages, by Type, 2021 (%)

• ACEI
• Angiotensin II Receptor Blockers
• ARNIs
• Beta Blockers
• Aldosterone Antagonists
• Diuretics

Global Heart Failure Drugs Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (MT)

Global Heart Failure Drugs Market Segment Percentages, by Application, 2021 (%)

• Reduced Ejection Fraction
• Preserved Ejection Fraction

Global Heart Failure Drugs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (MT)

Global Heart Failure Drugs Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Heart Failure Drugs revenues in global market, 2017-2022 (Estimated), ($ millions)

Key companies Heart Failure Drugs revenues share in global market, 2021 (%)

Key companies Heart Failure Drugs sales in global market, 2017-2022 (Estimated), (MT)

Key companies Heart Failure Drugs sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Novartis
• Pfizer
• AstraZeneca
• Hikma
• Teva
• Cipla
• Merck & Co.
• Amgen
• Roche
• Sun Pharma
• Mylan

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Heart Failure Drugs Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Heart Failure Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL HEART FAILURE DRUGS OVERALL MARKET SIZE

2.1 Global Heart Failure Drugs Market Size: 2021 VS 2028
2.2 Global Heart Failure Drugs Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Heart Failure Drugs Sales: 2017-2028

3 COMPANY LANDSCAPE

3.1 Top Heart Failure Drugs Players in Global Market
3.2 Top Global Heart Failure Drugs Companies Ranked by Revenue
3.3 Global Heart Failure Drugs Revenue by Companies
3.4 Global Heart Failure Drugs Sales by Companies
3.5 Global Heart Failure Drugs Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Heart Failure Drugs Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Heart Failure Drugs Product Type
3.8 Tier 1, Tier 2 and Tier 3 Heart Failure Drugs Players in Global Market
  3.8.1 List of Global Tier 1 Heart Failure Drugs Companies
  3.8.2 List of Global Tier 2 and Tier 3 Heart Failure Drugs Companies

4 SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 By Type - Global Heart Failure Drugs Market Size Markets, 2021 & 2028
  4.1.2 ACEI
  4.1.3 Angiotensin II Receptor Blockers
  4.1.4 ARNIs
  4.1.5 Beta Blockers
  4.1.6 Aldosterone Antagonists
  4.1.7 Diuretics
4.2 By Type - Global Heart Failure Drugs Revenue & Forecasts
  4.2.1 By Type - Global Heart Failure Drugs Revenue, 2017-2022
  4.2.2 By Type - Global Heart Failure Drugs Revenue, 2023-2028
  4.2.3 By Type - Global Heart Failure Drugs Revenue Market Share, 2017-2028
4.3 By Type - Global Heart Failure Drugs Sales & Forecasts
  4.3.1 By Type - Global Heart Failure Drugs Sales, 2017-2022
  4.3.2 By Type - Global Heart Failure Drugs Sales, 2023-2028
  4.3.3 By Type - Global Heart Failure Drugs Sales Market Share, 2017-2028
4.4 By Type - Global Heart Failure Drugs Price (Manufacturers Selling Prices), 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Heart Failure Drugs Market Size, 2021 & 2028
  5.1.2 Reduced Ejection Fraction
  5.1.3 Preserved Ejection Fraction
5.2 By Application - Global Heart Failure Drugs Revenue & Forecasts
  5.2.1 By Application - Global Heart Failure Drugs Revenue, 2017-2022
  5.2.2 By Application - Global Heart Failure Drugs Revenue, 2023-2028
  5.2.3 By Application - Global Heart Failure Drugs Revenue Market Share, 2017-2028
5.3 By Application - Global Heart Failure Drugs Sales & Forecasts
  5.3.1 By Application - Global Heart Failure Drugs Sales, 2017-2022
  5.3.2 By Application - Global Heart Failure Drugs Sales, 2023-2028
  5.3.3 By Application - Global Heart Failure Drugs Sales Market Share, 2017-2028
5.4 By Application - Global Heart Failure Drugs Price (Manufacturers Selling Prices), 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Heart Failure Drugs Market Size, 2021 & 2028
6.2 By Region - Global Heart Failure Drugs Revenue & Forecasts
  6.2.1 By Region - Global Heart Failure Drugs Revenue, 2017-2022
  6.2.2 By Region - Global Heart Failure Drugs Revenue, 2023-2028
  6.2.3 By Region - Global Heart Failure Drugs Revenue Market Share, 2017-2028
6.3 By Region - Global Heart Failure Drugs Sales & Forecasts
  6.3.1 By Region - Global Heart Failure Drugs Sales, 2017-2022
  6.3.2 By Region - Global Heart Failure Drugs Sales, 2023-2028
  6.3.3 By Region - Global Heart Failure Drugs Sales Market Share, 2017-2028
6.4 North America
  6.4.1 By Country - North America Heart Failure Drugs Revenue, 2017-2028
  6.4.2 By Country - North America Heart Failure Drugs Sales, 2017-2028
  6.4.3 US Heart Failure Drugs Market Size, 2017-2028
  6.4.4 Canada Heart Failure Drugs Market Size, 2017-2028
  6.4.5 Mexico Heart Failure Drugs Market Size, 2017-2028
6.5 Europe
  6.5.1 By Country - Europe Heart Failure Drugs Revenue, 2017-2028
  6.5.2 By Country - Europe Heart Failure Drugs Sales, 2017-2028
  6.5.3 Germany Heart Failure Drugs Market Size, 2017-2028
  6.5.4 France Heart Failure Drugs Market Size, 2017-2028
  6.5.5 U.K. Heart Failure Drugs Market Size, 2017-2028
  6.5.6 Italy Heart Failure Drugs Market Size, 2017-2028
  6.5.7 Russia Heart Failure Drugs Market Size, 2017-2028
  6.5.8 Nordic Countries Heart Failure Drugs Market Size, 2017-2028
  6.5.9 Benelux Heart Failure Drugs Market Size, 2017-2028
6.6 Asia
  6.6.1 By Region - Asia Heart Failure Drugs Revenue, 2017-2028
  6.6.2 By Region - Asia Heart Failure Drugs Sales, 2017-2028
  6.6.3 China Heart Failure Drugs Market Size, 2017-2028
  6.6.4 Japan Heart Failure Drugs Market Size, 2017-2028
  6.6.5 South Korea Heart Failure Drugs Market Size, 2017-2028
  6.6.6 Southeast Asia Heart Failure Drugs Market Size, 2017-2028
  6.6.7 India Heart Failure Drugs Market Size, 2017-2028
6.7 South America
  6.7.1 By Country - South America Heart Failure Drugs Revenue, 2017-2028
  6.7.2 By Country - South America Heart Failure Drugs Sales, 2017-2028
  6.7.3 Brazil Heart Failure Drugs Market Size, 2017-2028
  6.7.4 Argentina Heart Failure Drugs Market Size, 2017-2028
6.8 Middle East & Africa
  6.8.1 By Country - Middle East & Africa Heart Failure Drugs Revenue, 2017-2028
  6.8.2 By Country - Middle East & Africa Heart Failure Drugs Sales, 2017-2028
  6.8.3 Turkey Heart Failure Drugs Market Size, 2017-2028
  6.8.4 Israel Heart Failure Drugs Market Size, 2017-2028
  6.8.5 Saudi Arabia Heart Failure Drugs Market Size, 2017-2028
  6.8.6 UAE Heart Failure Drugs Market Size, 2017-2028

7 MANUFACTURERS & BRANDS PROFILES

7.1 Novartis
  7.1.1 Novartis Corporate Summary
  7.1.2 Novartis Business Overview
  7.1.3 Novartis Heart Failure Drugs Major Product Offerings
  7.1.4 Novartis Heart Failure Drugs Sales and Revenue in Global (2017-2022)
  7.1.5 Novartis Key News
7.2 Pfizer
  7.2.1 Pfizer Corporate Summary
  7.2.2 Pfizer Business Overview
  7.2.3 Pfizer Heart Failure Drugs Major Product Offerings
  7.2.4 Pfizer Heart Failure Drugs Sales and Revenue in Global (2017-2022)
  7.2.5 Pfizer Key News
7.3 AstraZeneca
  7.3.1 AstraZeneca Corporate Summary
  7.3.2 AstraZeneca Business Overview
  7.3.3 AstraZeneca Heart Failure Drugs Major Product Offerings
  7.3.4 AstraZeneca Heart Failure Drugs Sales and Revenue in Global (2017-2022)
  7.3.5 AstraZeneca Key News
7.4 Hikma
  7.4.1 Hikma Corporate Summary
  7.4.2 Hikma Business Overview
  7.4.3 Hikma Heart Failure Drugs Major Product Offerings
  7.4.4 Hikma Heart Failure Drugs Sales and Revenue in Global (2017-2022)
  7.4.5 Hikma Key News
7.5 Teva
  7.5.1 Teva Corporate Summary
  7.5.2 Teva Business Overview
  7.5.3 Teva Heart Failure Drugs Major Product Offerings
  7.5.4 Teva Heart Failure Drugs Sales and Revenue in Global (2017-2022)
  7.5.5 Teva Key News
7.6 Cipla
  7.6.1 Cipla Corporate Summary
  7.6.2 Cipla Business Overview
  7.6.3 Cipla Heart Failure Drugs Major Product Offerings
  7.6.4 Cipla Heart Failure Drugs Sales and Revenue in Global (2017-2022)
  7.6.5 Cipla Key News
7.7 Merck & Co.
  7.7.1 Merck & Co. Corporate Summary
  7.7.2 Merck & Co. Business Overview
  7.7.3 Merck & Co. Heart Failure Drugs Major Product Offerings
  7.7.4 Merck & Co. Heart Failure Drugs Sales and Revenue in Global (2017-2022)
  7.7.5 Merck & Co. Key News
7.8 Amgen
  7.8.1 Amgen Corporate Summary
  7.8.2 Amgen Business Overview
  7.8.3 Amgen Heart Failure Drugs Major Product Offerings
  7.8.4 Amgen Heart Failure Drugs Sales and Revenue in Global (2017-2022)
  7.8.5 Amgen Key News
7.9 Roche
  7.9.1 Roche Corporate Summary
  7.9.2 Roche Business Overview
  7.9.3 Roche Heart Failure Drugs Major Product Offerings
  7.9.4 Roche Heart Failure Drugs Sales and Revenue in Global (2017-2022)
  7.9.5 Roche Key News
7.10 Sun Pharma
  7.10.1 Sun Pharma Corporate Summary
  7.10.2 Sun Pharma Business Overview
  7.10.3 Sun Pharma Heart Failure Drugs Major Product Offerings
  7.10.4 Sun Pharma Heart Failure Drugs Sales and Revenue in Global (2017-2022)
  7.10.5 Sun Pharma Key News
7.11 Mylan
  7.11.1 Mylan Corporate Summary
  7.11.2 Mylan Heart Failure Drugs Business Overview
  7.11.3 Mylan Heart Failure Drugs Major Product Offerings
  7.11.4 Mylan Heart Failure Drugs Sales and Revenue in Global (2017-2022)
  7.11.5 Mylan Key News

8 GLOBAL HEART FAILURE DRUGS PRODUCTION CAPACITY, ANALYSIS

8.1 Global Heart Failure Drugs Production Capacity, 2017-2028
8.2 Heart Failure Drugs Production Capacity of Key Manufacturers in Global Market
8.3 Global Heart Failure Drugs Production by Region

9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS

9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints

10 HEART FAILURE DRUGS SUPPLY CHAIN ANALYSIS

10.1 Heart Failure Drugs Industry Value Chain
10.2 Heart Failure Drugs Upstream Market
10.3 Heart Failure Drugs Downstream and Clients
10.4 Marketing Channels Analysis
  10.4.1 Marketing Channels
  10.4.2 Heart Failure Drugs Distributors and Sales Agents in Global

11 CONCLUSION

12 APPENDIX

12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Key Players of Heart Failure Drugs in Global Market
Table 2. Top Heart Failure Drugs Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Heart Failure Drugs Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Heart Failure Drugs Revenue Share by Companies, 2017-2022
Table 5. Global Heart Failure Drugs Sales by Companies, (MT), 2017-2022
Table 6. Global Heart Failure Drugs Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Heart Failure Drugs Price (2017-2022) & (USD/MT)
Table 8. Global Manufacturers Heart Failure Drugs Product Type
Table 9. List of Global Tier 1 Heart Failure Drugs Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Heart Failure Drugs Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Heart Failure Drugs Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Heart Failure Drugs Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Heart Failure Drugs Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Heart Failure Drugs Sales (MT), 2017-2022
Table 15. By Type - Global Heart Failure Drugs Sales (MT), 2023-2028
Table 16. By Application – Global Heart Failure Drugs Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Heart Failure Drugs Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Heart Failure Drugs Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Heart Failure Drugs Sales (MT), 2017-2022
Table 20. By Application - Global Heart Failure Drugs Sales (MT), 2023-2028
Table 21. By Region – Global Heart Failure Drugs Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Heart Failure Drugs Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Heart Failure Drugs Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Heart Failure Drugs Sales (MT), 2017-2022
Table 25. By Region - Global Heart Failure Drugs Sales (MT), 2023-2028
Table 26. By Country - North America Heart Failure Drugs Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Heart Failure Drugs Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Heart Failure Drugs Sales, (MT), 2017-2022
Table 29. By Country - North America Heart Failure Drugs Sales, (MT), 2023-2028
Table 30. By Country - Europe Heart Failure Drugs Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Heart Failure Drugs Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Heart Failure Drugs Sales, (MT), 2017-2022
Table 33. By Country - Europe Heart Failure Drugs Sales, (MT), 2023-2028
Table 34. By Region - Asia Heart Failure Drugs Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Heart Failure Drugs Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Heart Failure Drugs Sales, (MT), 2017-2022
Table 37. By Region - Asia Heart Failure Drugs Sales, (MT), 2023-2028
Table 38. By Country - South America Heart Failure Drugs Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Heart Failure Drugs Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Heart Failure Drugs Sales, (MT), 2017-2022
Table 41. By Country - South America Heart Failure Drugs Sales, (MT), 2023-2028
Table 42. By Country - Middle East & Africa Heart Failure Drugs Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Heart Failure Drugs Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Heart Failure Drugs Sales, (MT), 2017-2022
Table 45. By Country - Middle East & Africa Heart Failure Drugs Sales, (MT), 2023-2028
Table 46. Novartis Corporate Summary
Table 47. Novartis Heart Failure Drugs Product Offerings
Table 48. Novartis Heart Failure Drugs Sales (MT), Revenue (US$, Mn) and Average Price (USD/MT) (2017-2022)
Table 49. Pfizer Corporate Summary
Table 50. Pfizer Heart Failure Drugs Product Offerings
Table 51. Pfizer Heart Failure Drugs Sales (MT), Revenue (US$, Mn) and Average Price (USD/MT) (2017-2022)
Table 52. AstraZeneca Corporate Summary
Table 53. AstraZeneca Heart Failure Drugs Product Offerings
Table 54. AstraZeneca Heart Failure Drugs Sales (MT), Revenue (US$, Mn) and Average Price (USD/MT) (2017-2022)
Table 55. Hikma Corporate Summary
Table 56. Hikma Heart Failure Drugs Product Offerings
Table 57. Hikma Heart Failure Drugs Sales (MT), Revenue (US$, Mn) and Average Price (USD/MT) (2017-2022)
Table 58. Teva Corporate Summary
Table 59. Teva Heart Failure Drugs Product Offerings
Table 60. Teva Heart Failure Drugs Sales (MT), Revenue (US$, Mn) and Average Price (USD/MT) (2017-2022)
Table 61. Cipla Corporate Summary
Table 62. Cipla Heart Failure Drugs Product Offerings
Table 63. Cipla Heart Failure Drugs Sales (MT), Revenue (US$, Mn) and Average Price (USD/MT) (2017-2022)
Table 64. Merck & Co. Corporate Summary
Table 65. Merck & Co. Heart Failure Drugs Product Offerings
Table 66. Merck & Co. Heart Failure Drugs Sales (MT), Revenue (US$, Mn) and Average Price (USD/MT) (2017-2022)
Table 67. Amgen Corporate Summary
Table 68. Amgen Heart Failure Drugs Product Offerings
Table 69. Amgen Heart Failure Drugs Sales (MT), Revenue (US$, Mn) and Average Price (USD/MT) (2017-2022)
Table 70. Roche Corporate Summary
Table 71. Roche Heart Failure Drugs Product Offerings
Table 72. Roche Heart Failure Drugs Sales (MT), Revenue (US$, Mn) and Average Price (USD/MT) (2017-2022)
Table 73. Sun Pharma Corporate Summary
Table 74. Sun Pharma Heart Failure Drugs Product Offerings
Table 75. Sun Pharma Heart Failure Drugs Sales (MT), Revenue (US$, Mn) and Average Price (USD/MT) (2017-2022)
Table 76. Mylan Corporate Summary
Table 77. Mylan Heart Failure Drugs Product Offerings
Table 78. Mylan Heart Failure Drugs Sales (MT), Revenue (US$, Mn) and Average Price (USD/MT) (2017-2022)
Table 79. Heart Failure Drugs Production Capacity (MT) of Key Manufacturers in Global Market, 2020-2022 (MT)
Table 80. Global Heart Failure Drugs Capacity Market Share of Key Manufacturers, 2020-2022
Table 81. Global Heart Failure Drugs Production by Region, 2017-2022 (MT)
Table 82. Global Heart Failure Drugs Production by Region, 2023-2028 (MT)
Table 83. Heart Failure Drugs Market Opportunities & Trends in Global Market
Table 84. Heart Failure Drugs Market Drivers in Global Market
Table 85. Heart Failure Drugs Market Restraints in Global Market
Table 86. Heart Failure Drugs Raw Materials
Table 87. Heart Failure Drugs Raw Materials Suppliers in Global Market
Table 88. Typical Heart Failure Drugs Downstream
Table 89. Heart Failure Drugs Downstream Clients in Global Market
Table 90. Heart Failure Drugs Distributors and Sales Agents in Global Market

List Of Figures

LIST OF FIGURES

Figure 1. Heart Failure Drugs Segment by Type
Figure 2. Heart Failure Drugs Segment by Application
Figure 3. Global Heart Failure Drugs Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global Heart Failure Drugs Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Heart Failure Drugs Revenue, 2017-2028 (US$, Mn)
Figure 7. Heart Failure Drugs Sales in Global Market: 2017-2028 (MT)
Figure 8. The Top 3 and 5 Players Market Share by Heart Failure Drugs Revenue in 2021
Figure 9. By Type - Global Heart Failure Drugs Sales Market Share, 2017-2028
Figure 10. By Type - Global Heart Failure Drugs Revenue Market Share, 2017-2028
Figure 11. By Type - Global Heart Failure Drugs Price (USD/MT), 2017-2028
Figure 12. By Application - Global Heart Failure Drugs Sales Market Share, 2017-2028
Figure 13. By Application - Global Heart Failure Drugs Revenue Market Share, 2017-2028
Figure 14. By Application - Global Heart Failure Drugs Price (USD/MT), 2017-2028
Figure 15. By Region - Global Heart Failure Drugs Sales Market Share, 2017-2028
Figure 16. By Region - Global Heart Failure Drugs Revenue Market Share, 2017-2028
Figure 17. By Country - North America Heart Failure Drugs Revenue Market Share, 2017-2028
Figure 18. By Country - North America Heart Failure Drugs Sales Market Share, 2017-2028
Figure 19. US Heart Failure Drugs Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Heart Failure Drugs Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Heart Failure Drugs Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Heart Failure Drugs Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Heart Failure Drugs Sales Market Share, 2017-2028
Figure 24. Germany Heart Failure Drugs Revenue, (US$, Mn), 2017-2028
Figure 25. France Heart Failure Drugs Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Heart Failure Drugs Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Heart Failure Drugs Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Heart Failure Drugs Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Heart Failure Drugs Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Heart Failure Drugs Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Heart Failure Drugs Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Heart Failure Drugs Sales Market Share, 2017-2028
Figure 33. China Heart Failure Drugs Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Heart Failure Drugs Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Heart Failure Drugs Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Heart Failure Drugs Revenue, (US$, Mn), 2017-2028
Figure 37. India Heart Failure Drugs Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Heart Failure Drugs Revenue Market Share, 2017-2028
Figure 39. By Country - South America Heart Failure Drugs Sales Market Share, 2017-2028
Figure 40. Brazil Heart Failure Drugs Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Heart Failure Drugs Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Heart Failure Drugs Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Heart Failure Drugs Sales Market Share, 2017-2028
Figure 44. Turkey Heart Failure Drugs Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Heart Failure Drugs Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Heart Failure Drugs Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Heart Failure Drugs Revenue, (US$, Mn), 2017-2028
Figure 48. Global Heart Failure Drugs Production Capacity (MT), 2017-2028
Figure 49. The Percentage of Production Heart Failure Drugs by Region, 2020 VS 2027
Figure 50. Heart Failure Drugs Industry Value Chain
Figure 51. Marketing Channels